Inflammation and Metabolic Stress Uncover a New Cell Death Pathway
Scientists at St. Jude Children’s Research Hospital have identified a previously unknown form of cell death that emerges when inflammation and metabolic stress collide — a discovery that could open new avenues for cancer treatment. The findings, published in Cell, describe a mechanism the researchers have named mitoxyperilysis, highlighting the critical role of mitochondria in driving cellular self-destruction under extreme conditions.
In many diseases, including infections and cancer, the body simultaneously experiences activation of the innate immune system and a scarcity of nutrients. Until now, these processes were largely studied in isolation. The St. Jude team found that when they occur together, they trigger a unique inflammatory cell death pathway with distinct biological hallmarks.
“We discovered that innate immune and metabolic disruptions acted synergistically to activate this new pathway,” said senior author Dr. Thirumala-Devi Kanneganti, director of the St. Jude Center of Excellence for Innate Immunity and Inflammation. “By defining the underlying mechanism, we’ve identified molecular checkpoints that could be targeted for future therapeutic interventions.”
At the center of mitoxyperilysis are mitochondria, the structures commonly known as the powerhouses of the cell. Under normal conditions, mitochondria move freely to generate energy. When damaged, however, they produce reactive oxygen species — unstable molecules capable of causing cellular harm. Using advanced microscopy, researchers observed that when immune activation coincides with nutrient limitation, damaged mitochondria become immobilized near the cell membrane.
That prolonged contact proved fatal. The reactive oxygen species released at the membrane caused localized oxidative damage until the membrane ruptured, leading to a burst-like inflammatory cell death.
“We saw mitochondria remain anchored to the membrane until the cells lysed at those exact contact points,” explained first author Dr. Yaqiu Wang, of the St. Jude Department of Immunology. “This mechanism does not align with any previously described form of cell death, confirming mitoxyperilysis as a novel pathway.”
Further investigation revealed that the process is tightly regulated by both immune and metabolic signaling. A key player is mTOR, a major metabolic regulator. When mTOR activity was blocked, mitochondria retreated from the membrane and cell death was prevented. Similarly, disabling innate immune receptors halted the process entirely, underscoring the necessity of both signals working in tandem.
The discovery carries promising implications for cancer research. Tumors often face intense metabolic stress while also interacting with immune signals. In experimental models, the researchers showed that activating innate immunity while restricting nutrients led to significant tumor regression — an effect not seen when either strategy was used alone.
By bridging immunology and metabolism, the study demonstrates how combining scientific disciplines can yield fundamentally new insights. As Dr. Kanneganti noted, mitoxyperilysis not only deepens understanding of cell death but also points toward innovative combination therapies that may one day improve cancer care.
